Dr. Jaskaran Singh Sethi

MD, DNB (Radiation Oncology)

Sr. Consultant & Chief of GI, GU, HPB, & TBT Radiation Oncology Services

Book an Appointment

RGCIRC, Rohini, Delhi - 110 085

RGCIRC, Niti Bagh, Delhi - 110049

About

Dr. Jaskaran Singh Sethi, is a renowned radiation oncologist in India, with more than 18 years of experience in the field of radiotherapy and cancer treatment. He was a member of the team to start first Image guided radiotherapy program in the country. He is a graduate from MS Medical Institute and then did his Radiation oncology training from MD Oswal Cancer Treatment & Research foundation, Ludhiana.

During his career, he has worked with premier institutes of the country. He is proficient in treatment planning and delivery of the latest techniques in the field of radiation oncology. He has special interest in stereotactic body radiotherapy, radiosurgery and the management of motion during radiation therapy treatments.

He has written and published scientific papers in various national and international journals. He is involved in the PG training program of the Institute and research activities at both national and international levels.

He is passionate about quality standards in healthcare and is a qualified assessor with NABH, Quality control of India and NHSRC-Government of India.

Specialized Areas

Precision Radiation Oncology
Stereotactic Body Radiotherapy (SBRT) to Liver, Pancreas, Stereotactic radiosurgery (SRS) Brain
Image guided Radiotherapy (IGRT), Intensity modulated Radiotherapy (IMRT), 3-D Conformal RT
Motion management in radiotherapy
Image guided brachytherapy, Liver brachytherapy, intra-luminal brachytherapy
Pediatric radiation oncology, Gastro-intestinal radiation oncology,

Educational Background

MD, MS Medical Institute, 1997
DNB (Radiotherapy) 2003

Experience

Director Radiation Oncology Fortis Hospital, Shalimar Bagh & Noida: 2015-2019
Consultant Radiation Oncology, Action Cancer Hospital, Delhi: 2012-2015
Consultant Radiation Oncology, SMH HCG, Delhi: 2008-2012
Professor, SGRD Institute of Medical Sciences, Amritsar: 2006-2008
Resident Radiation Oncology, Apollo hospital, Sarita Vihar, Delhi: 2004-2006
Fellowship training at AIIMS, Delhi: 2006
Junior resident, Radiation Oncology, MD Oswal Cancer Treatment & Research Foundation, Ludhiana

Professional Journey

Achievements

Member of the team to start first Image guided Radiotherapy program in North India 2008
Established Cancer Centre in Alwar 2008
Established the department of Radiotherapy at Fortis Shalimar Bagh 2017
European Society of Therapeutic Radiation Oncology (ESTRO) Training on Image guided radiotherapy in university of Brussels, Belgium 2009
ESTRO training on Head & Neck Cancers 2013
Sr. Vice President NZ AROI 2022-2024
Editor-in-chief of journal of NZ AROI 2024
Quality assessor with NABH and National Health System Resource Centre (NHSRC)
Associated with Indraprastha University, New Delhi as an assessor

Awards

International travel fellowship
Frank Neal Fellowship
Best Paper runners-up award at North Zone AROI 2003
Winner PG Quiz competition 2003

Publication

DE_HyART trial: Study protocol for phase 2 randomised controlled study assessing the role of dose escalation using [18F] FMISO PET CT in head and neck cancers, July 2024
Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort, December 2022, The British journal of radiology96(1143)
Treatment Delay during Radiotherapy of Cancer Patients due to COVID-19 Pandemic, June 2022, Asian Pacific Journal of Cancer Prevention23(7):2415-2420
Evaluation and Correlation of Radiological and Pathological Response Following Neoadjuvant Short-course Radiotherapy Followed by Chemotherapy Followed by Surgery in Resectable Locally Advanced Adenocarcinoma of the Rectum. Journal of Current Oncology. 2023;6(2):94-104. doi:10.1177/25898892241264901
Bifocal intracranial germ cell tumor: A diagnostic and therapeutic dilemma for radiation oncologists, May 2023, Journal of Cancer Research and Therapeutics20(5):1636-1639
Immunoscore-based wait-and-watch after short course radiation and chemotherapy in rectal cancer. April 2024. Radiotherapy and Oncology, 194:S1489-S1491.
Primary Oropharyngeal SMARCA4-Deficient Carcinoma: Expanding the Diagnostic Spectrum in Head and Neck Cancer, March 2024, Head and Neck Pathology:18(1)
Impact of Radiation Treatment Delay Due to COVID-19 Pandemic, October 2022, International Journal of Radiation Oncology*Biology*Physics114(3):e330
Clinical outcomes of neoadjuvant chemoradiation in oesophageal cancer, July 2021, Radiotherapy and Oncology161:S715-S716
Evaluation of response rate of chemo-radiation and brachytherapy in patients with locally advanced carcinoma cervix in a tertiary care hospital. IJRMS Vol 8. No4(2020) pp1361-1365
Chapter on Cancer in book Vitamin E, a comprehensive compendium published by Springer 2018.
Adjuvant Treatment of Primary brain tumors using radiotherapy along with Temozolomide chemotherapy in the Peer Review Journal, 1^st issue, 2005.
Impact of treatment time on the outcome in carcinoma of uterine cervix. Published in Journal of Clinical Radiotherapy & Oncology, Vol 4, No 2, 2004, pp42-49.
Chapter on Organ preservation in cancer. Published in New Horizons in Surgery, March 2003.
Synchronous presentation of Carcinoma Breast & Vulva, A rare presentation, Published in Journal of Clinical Radiotherapy & Oncology, Vol 3, No 1, 2003, pp25-26.
Role of Paclitaxel as a radio sensitizing agent in advanced stages of Head & Neck cancers, Intl. Journal of cancer: supplement Vol13: 2002, p. 427
Role of interstitial brachytherapy boosts along with external radiotherapy in carcinoma tongue (anterior 2/3^rd) Journal of cancer: supplement Vol13: 2002, p.261
Concomitant chemoradiotherapy in advanced carcinoma cervix using Cisplatin as a radio-sensitizer, Intl. Journal of cancer: supplement Vol13: 2002 p. 460.